FDA 483 - Reading Hospital - July 30, 2025

An FDA inspection of Reading Hospital's blood bank identified significant deficiencies. The firm failed to thoroughly investigate unexplained discrepancies in blood product testing and temperature control for platelet units. Additionally, the inspection revealed a failure to maintain quality control records for blood storage equipment and to complete required incident reports for equipment failures.